![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
AL Marrow, JR Pace, RH Purdy and SM Paul
Section of Molecular Pharmacology, National Institute of Mental Health, Bethesda, Maryland 20892.
The potentiation of gamma-aminobutyric acid (GABA) receptor-mediated 36Cl- uptake by various steroids has been characterized in rat cerebral cortical synaptoneurosomes. Several of these steroids, including 3 alpha-hydroxy-5 alpha-pregnan-20-one (3 alpha-OH-DHP) and 3 alpha,21- dihydroxy-5 alpha-pregnan-20-one (THDOC), increase the potency of muscimol to stimulate 36Cl- uptake in a concentration-dependent and stereospecific manner. Concentration-response curves for 3 alpha-OH- DHP, THDOC, 3 alpha-hydroxy-pregn-4-en-20-one, and pentobarbital enhancement of muscimol-stimulated 36Cl- uptake are biphasic, with Hill coefficients significantly less than 1.0. Computer-modeling (ALLFIT analysis) of these curves suggests that these steroids and pentobarbital interact with multiple binding sites on GABAA receptor(s). In contrast, the concentration-response curve for THDOC 21- mesylate is monophasic, with a smaller maximal response, and yields a Hill coefficients of 1.0. In addition to modulating GABA receptor- mediated 36Cl- uptake, THDOC enhanced the ability of the benzodiazepine clonazepam to potentiate muscimol-stimulated 36Cl- uptake. The central benzodiazepine antagonist Ro15-1788 failed to inhibit THDOC-induced potentiation of muscimol-stimulated 36Cl- uptake, although it has been previously reported to inhibit some of the behavioral actions of THDOC. In contrast to the A ring-reduced metabolites and analogues of progesterone and deoxycorticosterone, glucocorticoids had no effect on muscimol-stimulated 36Cl- uptake in cerebral cortical synaptoneurosomes at concentrations between 20 nM and 5 microM.
This article has been cited by other articles:
|
|
 |
|
  J. A. Lieberman, F. P. Bymaster, H. Y. Meltzer, A. Y. Deutch, G. E. Duncan, C. E. Marx, J. R. Aprille, D. S. Dwyer, X.-M. Li, S. P. Mahadik, et al. Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection Pharmacol. Rev., September 1, 2008; 60(3): 358 - 403. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Akk, P. Li, J. Bracamontes, D. E. Reichert, D. F. Covey, and J. H. Steinbach Mutations of the GABA-A Receptor {alpha}1 Subunit M1 Domain Reveal Unexpected Complexity for Modulation by Neuroactive Steroids Mol. Pharmacol., September 1, 2008; 74(3): 614 - 627. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-L. Wang, C.-C. Ou, and J. Y.H. Chan Receptor-Independent Activation of GABAergic Neurotransmission and Receptor-Dependent Nontranscriptional Activation of Phosphatidylinositol 3-kinase/Protein Kinase Akt Pathway in Short-Term Cardiovascular Actions of Dexamethasone at the Nucleus Tractus Solitarii of the Rat Mol. Pharmacol., February 1, 2005; 67(2): 489 - 498. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Zhu, V. Birzniece, T. Backstrom, and G. Wahlstrom Dynamic aspects of acute tolerance to allopregnanolone evaluated using anaesthesia threshold in male rats Br. J. Anaesth., October 1, 2004; 93(4): 560 - 567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. J. MacLusky, T. Hajszan, and C. Leranth Effects of Dehydroepiandrosterone and Flutamide on Hippocampal CA1 Spine Synapse Density in Male and Female Rats: Implications for the Role of Androgens in Maintenance of Hippocampal Structure Endocrinology, September 1, 2004; 145(9): 4154 - 4161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Sanna, G. Talani, F. Busonero, M. G. Pisu, R. H. Purdy, M. Serra, and G. Biggio Brain Steroidogenesis Mediates Ethanol Modulation of GABAA Receptor Activity in Rat Hippocampus J. Neurosci., July 21, 2004; 24(29): 6521 - 6530. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. W. Morris and J. Amin Insight into the Mechanism of Action of Neuroactive Steroids Mol. Pharmacol., July 1, 2004; 66(1): 56 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. D. Griffin and S. H. Mellon Biosynthesis of the Neurosteroid 3{alpha}-Hydroxy-4-pregnen-20-one (3{alpha}HP), a Specific Inhibitor of FSH Release Endocrinology, November 1, 2001; 142(11): 4617 - 4622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Fujii and S. H. Mellon Regulation of Uterine {{gamma}}-Aminobutyric AcidA Receptor Subunit Expression throughout Pregnancy Endocrinology, May 1, 2001; 142(5): 1770 - 1777. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. R. Engel, R. H. Purdy, and K. A. Grant Characterization of Discriminative Stimulus Effects of the Neuroactive Steroid Pregnanolone J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 489 - 495. [Abstract] [Full Text]
|
|
|
|
|
|
C. S. Goodchild, A. Robinson, and R. Nadeson Antinociceptive properties of neurosteroids IV: pilot study demonstrating the analgesic effects of alphadolone administered orally to humans Br. J. Anaesth., April 1, 2001; 86(4): 528 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Evans, B. T. Searcy, and F. L. Moore A Subset of Kappa Opioid Ligands Bind to the Membrane Glucocorticoid Receptor in an Amphibian Brain Endocrinology, July 1, 2000; 141(7): 2294 - 2300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. F. Covey, D. Nathan, M. Kalkbrenner, K. R. Nilsson, Y. Hu, C. F. Zorumski, and A. S. Evers Enantioselectivity of Pregnanolone-Induced gamma -Aminobutyric AcidA Receptor Modulation and Anesthesia J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 1009 - 1016. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. M. Mihalek, P. K. Banerjee, E. R. Korpi, J. J. Quinlan, L. L. Firestone, Z.-P. Mi, C. Lagenaur, V. Tretter, W. Sieghart, S. G. Anagnostaras, et al. Attenuated sensitivity to neuroactive steroids in gamma -aminobutyrate type A receptor delta subunit knockout mice PNAS, October 26, 1999; 96(22): 12905 - 12910. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. W. Morris, C. N. Moorefield, and J. Amin Differential Modulation of the gamma -Aminobutyric Acid Type C Receptor by Neuroactive Steroids Mol. Pharmacol., October 1, 1999; 56(4): 752 - 759. [Abstract] [Full Text]
|
|
|
|
|
|
K. Ukena, C. Kohchi, and K. Tsutsui Expression and Activity of 3{beta}-Hydroxysteroid Dehydrogenase/{Delta}5-{Delta}4-Isomerase in the Rat Purkinje Neuron during Neonatal Life Endocrinology, February 1, 1999; 140(2): 805 - 813. [Abstract] [Full Text]
|
|
|
|
|
|
M. Beekman, J. T. Ungard, M. Gasior, R. B. Carter, D. Dijkstra, S. R. Goldberg, and J. M. Witkin Reversal of Behavioral Effects of Pentylenetetrazol by the Neuroactive Steroid Ganaxolone J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 868 - 877. [Abstract] [Full Text]
|
|
|
|
|
|
K. Ukena, M. Usui, C. Kohchi, and K. Tsutsui Cytochrome P450 Side-Chain Cleavage Enzyme in the Cerebellar Purkinje Neuron and Its Neonatal Change in Rats Endocrinology, January 1, 1998; 139(1): 137 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. F. Tyndale, S. V. Bhave, E. Hoffmann, P. L. Hoffman, B. Tabakoff, A. J. Tobin, and R. W. Olsen Pentobarbital Decreases the gamma -Aminobutyric AcidA Receptor Subunit gamma-2 Long/Short mRNA Ratio by a Mechanism Distinct from Receptor Occupation J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 350 - 357. [Abstract] [Full Text]
|
|
|
|
|
|
M. Gasior, R. B. Carter, S. R. Goldberg, and J. M. Witkin Anticonvulsant and Behavioral Effects of Neuroactive Steroids Alone and in Conjunction with Diazepam J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 543 - 553. [Abstract] [Full Text]
|
|
|
|
|
|
J. A. Vivian, H. M. T. Barros, A. Manitiu, and K. A. Miczek Ultrasonic Vocalizations In Rat Pups: Modulation at the gamma -Aminobutyric AcidA Receptor Complex and the Neurosteroid Recognition Site, J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 318 - 325. [Abstract] [Full Text]
|
|
|
|
 |
|
 M Orchinik, T. Murray, and F. Moore A corticosteroid receptor in neuronal membranes Science, June 28, 1991; 252(5014): 1848 - 1851. [Abstract] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
